Site Navigation
Skip to content
Back to MainLineHealth.org
(External)
Toggle Menu
About
Nav item with submenu
Leadership
Our History and Accomplishments
Milestones
Our Location
Endowed Chairs
Catalyst Magazine
Contact Us
Researchers
Nav item with submenu
Our Researchers
Publications
Programs
Nav item with submenu
Cancer Research
Cardiovascular Disease Research
Clinical Research Center
Research for Other Diseases and Conditions
Services
Tech Development
Nav item with submenu
Acapreneurial
Intellectual Property and Other Technology
Biotech Incubator
Lankenau Ventures
Back to MainLineHealth.org
(External)
About
Nav item with submenu
Leadership
Our History and Accomplishments
Milestones
Our Location
Endowed Chairs
Catalyst Magazine
Contact Us
Researchers
Nav item with submenu
Our Researchers
Publications
Programs
Nav item with submenu
Cancer Research
Cardiovascular Disease Research
Clinical Research Center
Research for Other Diseases and Conditions
Services
Tech Development
Nav item with submenu
Acapreneurial
Intellectual Property and Other Technology
Biotech Incubator
Lankenau Ventures
Clinical Trials
Search
What can we help you find?
Search
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Jump to Section
Jump to Section
Find a Provider
Find a Doctor
